A novel cell-free synthetic biology-based technology for low-volume, visually interpretable micronutrient tests. Suitable for field applications, it offers colorimetric and fluorescent readouts for semi-quantitative and quantitative assessments, respectively.
This innovative solution uses cell-free synthetic biology to develop low-volume, visually interpretable assays for diagnostic applications. Using processed bacterial lysates, we leverage cellular functions like transcription and translation for in vitro sensing of molecular targets and transduction of that signal into measurable (and usually visually interpretable) outputs. This yields a user-friendly, point-of-need test that can provide colorimetric readouts for quick, semi-quantitative assessments or fluorescent readouts for more accurate, fully-quantitative measurements using simple devices like a cell phone.
This technology is at TRL 4, as it has been validated in a laboratory environment. Future work includes collaborating with sponsors to refine assay formats and develop new sensors, adapting the technology for practical deployment.
Georgia Institute of Technology is a large, technology‑focused public research university in Atlanta with a strong applied research culture. Industry engages through the Georgia Tech Research Institute for contract R&D, a Midtown innovation district with co‑located corporate labs, and a statewide manufacturing extension to support scale‑up. A long‑standing partnership with a major academic medical center enables clinical translation, and a large co‑op program delivers a steady talent pipeline. Research is backed by competitive federal funding from NSF, NIH, DOE, DoD, and NASA. Technology commercialization is managed by the Georgia Tech Research Corporation, with dedicated licensing, corporate contracting, and startup support.